-
Product Insights
NewGuerbet SA Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Guerbet SA Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Guerbet SA (Guerbet) is a manufacturer of contrast agents. The company provides a wide range of imaging products, solutions, and services for Computed Tomography (CT)/Cath Lab examinations, magnetic resonance imaging (MRI), and interventional imaging. CT/Cath Lab contrast agents consist of iodinated active ingredients, and few examinations of the digestive tract use barium-based products. MRI imaging uses gadolinium complexes. Guerbet has...
-
Product Insights
NewShanghai United Imaging Healthcare Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Shanghai United Imaging Healthcare Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Shanghai United Imaging Healthcare Co Ltd (United Imaging) develops and manufactures advanced medical imaging, radiotherapy equipment and life science instruments. The company's product portfolio comprises computed tomography systems, molecular imaging devices, digital radiography, magnetic resonance equipment and radiotherapy systems among others. The company also provides tailored project management solutions, medical IT solutions, monitoring services and customized...
-
Product Insights
NewiCAD Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our iCAD Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. iCAD Inc (iCAD) is a medical technology company that provides advanced image analysis, radiation therapies and workflow solutions for the early disclosure and treatment of cancers. The company offers cancer detection products and solutions which include Powerlook, VeraLook and ProFound AI and magnetic resonance imaging (MRI) applications for diagnostic purposes. It also provides Xoft System, a proprietary electronic brachytherapy platform...
-
Product Insights
NewInSightec Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our InSightec Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. InSightec Ltd (InSightec) a subsidiary of Elbit Imaging Ltd, is a medical device company that develops and markets magnetic resonance imaging ultrasound based medical devices. The company offers products through divisions such as neurosurgery, urology, oncology and womens’ health. Its services include commercial development advisory, free professional services, free platform upgrade, onsite support, parts warranty, periodic maintenance, onsite clinical training,...
-
Product Insights
NewNeusoft Medical Systems Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Neusoft Medical Systems Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Neusoft Medical Systems Co Ltd (Neusoft Medical), a subsidiary of Neusoft Corp is a medical device company that provides medical equipment and services. The company offers medical imaging equipment, e-hospital solutions, regional medical and personal healthcare products. Its product portfolio includes computed tomography, magnetic resonance imaging products, x-ray, radiotherapy products, ultrasound, positron emission tomography, linear accelerator and...
-
Product Insights
NewSiemens Healthineers AG Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Siemens Healthineers AG Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Siemens Healthineers AG (Siemens Healthineers), a subsidiary of Siemens AG, is a medical technology company that designs, develops, produces, and distributes diagnostic imaging systems, clinical and workflow systems and solutions, and systems for minimally invasive procedures. The company’s major products include molecular imaging systems, X-ray products, ultrasound systems, computed tomography systems, magnetic resonance imaging systems, testing systems, point-of-care (POC)...
-
Product Insights
NewT2 Biosystems Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our T2 Biosystems Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. T2 Biosystems Inc (T2 Biosystems) is an in-vitro diagnostics company. It offers clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. T2 Biosystems offers T2HemoStat panel, T2Plex for research, T2Plex instrument and T2Lyme panels. The company also...
-
Product Insights
Likelihood of Approval Analysis for Malignant Fibrous Histiocytoma
Overview How likely is it that the drugs in Malignant Fibrous Histiocytoma will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Malignant Fibrous Histiocytoma Overview Malignant fibrous histiocytoma, now termed undifferentiated pleomorphic...
-
Product Insights
PTCA Drug Coated Balloon (DCB) Catheters Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
PTCA Drug Coated Balloon (DCB) Catheters Pipeline Market Report Overview A Drug Coated Balloon (DCB) Catheter is an anti-restenotic drug coated PTCA balloon catheter intended to prevent re-narrowing of the coronary arteries. The PTCA Drug Coated Balloon (DCB) Catheters pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Upadacitinib ER in Polyarticular Juvenile Idiopathic Arthritis (PJIA)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Upadacitinib ER in Polyarticular Juvenile Idiopathic Arthritis (PJIA) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Upadacitinib ER in Polyarticular Juvenile Idiopathic Arthritis...